... was a reduced risk for all-cause mortality (50, 75, 110, 150 mg 2×day dose), cardiac mortality (110, 150 mg 2×day) and stroke (50, 75, 110, 150 mg 2×day dose) in response ...

... Median survival 20 months 20 years Developmental delay >50% >75% Hypotonia >50% >75% Muscular atrophy >50% 25%-50% Feeding problems Equally ... Liver involvement 40% Not reported Hearing impairment 20%-50% >75% Dystonia 25%-50% >75% Hypertonia 25%-50% <20% ...

... Committee considered by consensus that an intake of 50-75% of usual volumes should be considered as borderline ... difficulty with breastfeeding or inadequate oral fluid intake (50-75% of usual volume, taking account of risk factors [ ...

... 70 to 0.81; 8 studies). 46 , 48 , 50 , 75 , 78 , 79 , 85 , 88 Figure 8 Sensitivity and ... 0.17), based on 10 studies. 46 , 48 , 50 , 75 , 79 , 81 , 82 , 85 - 87 Similar patterns for ...

... disability Speech & language delay Friendly/amiable disposition Common (50%-75%) Structural brain anomalies Ventriculomegaly Aplasia/hypoplasia of corpus ...

... 1q21.1, and one R8BM8A hypomorphic allele. About 50%-75% of probands have inherited the deletion (null allele) ... alleles in the population (see Molecular Genetics ). Approximately 50%-75% of probands have inherited the 200-kb minimally ...

... 40 & 50 yrs Every 2 yrs between ages 50 & 75 yrs Endometrial cancer Transvaginal ultrasound examination & endometrial biopsy ...